PUBLICATIONS

1 – Dear RF, McGeechan K, Jenkins M, Barratt A, Tattersall MHN, Wilcken N. Meta-analysis resolves the role of combination versus sequential chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD008792.DOI: 10.1002/14651858.CD008792.pub2.
2 – Dear RF, McGeechan K, Jenkins M, Barratt A, Tattersall M, Wilcken N. Meta-analysis resolves the role of combination versus sequential chemotherapy for metastatic breast cancer. The Breast 2013; 22:Supplement 3:S32.
3 – Dear RF, Barratt AL, Evans A, Simes J, Newsom J, Kent D, Crossing S, Holliday C, Segelov S, Hruby G, Tattersall MHN. Identifying and prioritising gaps in colorectal cancer trials research in Australia. Medical Journal of Australia 2012; 197(9):507-511.
4 – Dear RF, Barratt AL, Askie L, Butow PN, McGeechan K, Crossing S, Currow D, Tattersall MHN. Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trial. Annals of Oncology 2012; 23:1912-1918.
5 – Dear RF, Barratt AL, Tattersall MHN. Barriers to recruitment in cancer trials: no longer medical oncologists’ attitudes. Letter to the editor. Medical Journal of Australia 2012; 196(2):112-113
6 – Dear RF, Kelly PJ, Wright GM, Stalley P, McCaughan BC, Tattersall MHN. Pulmonary metastatsectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia Pacific Journal of Clinical Oncology. In press. Accepted 24 December 2011.
7 – Dear RF, Barratt AL, Crossing S, Butow PN, Hanson S, Tattersall MHN. Consumer input into research: the Australian Cancer Trials website. Health Research Policy and Systems 2011;9(1):30
8 – Dear RF, Barratt AL, McGeechan K, Askie L, Simes J, Tattersall MHN. Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Medical Journal of Australia 2011;194(8):387-91
9 – Dear RF, Barratt A, Askie L, McGeechan K, Arora S, Crossing S, Currow D, Tattersall M. Adding value to clinical trial registries: insights from Australian Cancer Trials Online, a website for consumers. Clinical Trials 2011;8(1):70-6
10 – Dear RF, Tattersall MHN, McGeechan K, Barratt A, Wilcken N. Combination versus sequential single agent chemotherapy for metastatic breast cancer (Protocol). The Cochrane Library. Issue 10. 6 October 2010
11 – Dear RF, Gao B, Harnett P. Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience. Asia Pacific Journal of Clinical Oncology 2010; 6(1): 66-73
12 – Dear RF, Tattersall MHN. The role of pulmonary metastasectomy in osteosarcoma and soft tissue sarcoma. Cancer Forum 2010; 34 (3): 149-153
13 – Dear RF, Tattersall MHN, McGeechan K, Vaughan M. Factors associated with Australian and New Zealand oncologists’ future work preferences. Asia Pacific Journal of Clinical Oncology 2011; 7(1):56-64
14 – Tattersall MHN, Dear RF, Jansen J, Shepherd HL, Devine RJ, Horvarth LG, Boyer ML. Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Medical Journal of Australia 2009; 191:209-212
15 – Dear RF, Tattersall MHN. Rediscovering university teaching hospitals for Australia. Medical Journal of Australia 2009; 190: 285-286.
16 – Wilcken N, Dear RF. Chemotherapy in metastatic breast cancer: a summary of all randomised trials reported 2000-2007. European Journal of Cancer 2008; 44; 2218-2225
17 – Dear RF, Wilcken N, Shannon J. Beyond Chemotherapy: Demystifying the New “Targeted” Cancer Treatments. Australian Family Physician 2008; 37:45-49
18 – Gurney H, Shaw R. Obesity in dose calculation: A mouse or an elephant? Journal of Clinical Oncology 2007; 25:4703-4704